您的位置: 首页 > 农业专利 > 详情页

Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy
专利权人:
发明人:
申请号:
EP10003287.9
公开号:
EP2202297B1
申请日:
2008.07.18
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
Like Gemcitabine, irinotecan, doxorubicin and cisplatin, other chemotherapeutic agents can inhibit the growth of an oncolytic vaccinia virus. As such, they can control viral titer in a subject. Such compounds can be used for the treatment or amelioration of side affects associated with oncolytic virus therapy, or for controlling the oncolytic virus load in a subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充